Rajarshi Janak University (RJU), Central Examination Administration and Records Centre, Janakpurdham, has published the examination results of regular students enrolled in the BSc MLT and BPH academic programs conducted under the semester system.
According to the notice issued on 2083/07/09 BS, the results have been published following a decision of the Central Examination Administration and Records Council.
Roll Numbers of Successful Candidates
The following candidates from Rajarshi Janak School of Health Science, Janakpurdham, have passed their respective examinations.
BSc MLT – Eighth Semester (2022 Batch Regular)
Roll Numbers of Successful Candidates:
41518001, 41518002, 41518003, 41518004, 41518005, 41518006
BPH – Eighth Semester (2022 Batch Regular)
Roll Numbers of Successful Candidates:
41528001, 41528002, 41528003, 41528004, 41528005, 41528006, 41528007, 41528008, 41528009
Information Regarding Marksheets
Students can obtain their examination marksheets from Rajarshi Janak School of Health Science, Janakpurdham, after 7 (seven) days, as stated in the notice.
Retotaling Application Procedures
Students who are dissatisfied with their examination results and wish to apply for retotaling must submit their applications within 7 (seven) days from the date of receiving their marksheets.
The following requirements and procedures apply:
Retotaling Fee: NPR 500 (five hundred rupees) per subject.
Bank Details: The prescribed fee must be deposited into the account maintained in the name of the Centre at Rastriya Banijya Bank, Pidari Branch, Janakpurdham.
Account Number: 152010000279001
Application Submission: Students must submit their retotaling applications to Rajarshi Janak School of Health Science, Janakpurdham, along with the original bank deposit voucher.
The notice further states that although efforts have been made to publish the examination results with minimal errors, any discrepancies arising from printing or other reasons will be corrected based on the office's official records.
Published Date: 2083/07/09 BS

Comments 0
No comments yet. Be the first to start the conversation.